placebo compound

DIETARY_SUPPLEMENT2 trials

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Örebro University, Sweden

Conditions

Microscopic ColitisMuscle InflammationMuscular Dystrophies

Unknown Phase

Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies

CompletedNCT03317171

Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoMuscle Inflammation, Muscular Dystrophies

Start: 2016-02-28End: 2016-12-31Updated: 2017-10-25

Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre

Örebro University, SwedenMicroscopic Colitis

Start: 2021-11-03End: 2022-12-30Target: 40Updated: 2022-04-21

Related Papers

The Effects of Fermentable Dietary Fibre Supplementation on Intestinal Barrier Function, Intestinal Microbiome, and Inflammation in Microscopic Colitis Patients—A Randomised, Triple-Blinded, Placebo-Controlled Trial

2024-02-04

Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial

Frontiers in Neurology2019-07-2329 citations